Research!America

Research, Industry, Academic and Patient Groups Join Forces for Week of Advocacy to Save Research, November 12-16, 2012 WASHINGTON ’€“ November 1, 2012 ’€“ Research!America, along with several dozen patient, industry, academic and health organizations, has coordinated a Week of Advocacy to Save Research for the week of November 12-16, 2012. The unified campaign is intended to convince policy makers to champion medical innovation, rather than undercut it, as decisions are made to address the ’€œfiscal cliff.’€ The campaign ’€” We Need Cures, Not Cuts ’€”is designed to raise awareness about the importance of making biomedical and health research a higher national priority. The campaign will...
Pending Budget Cuts will Further Jeopardize Global Leadership in Research and Innovation WASHINGTON, DC ’€”October 25, 2012’€”Biomedical and health research and development (R&D) spending from all sources declined by more than $4 billion or 3% between FY10 and FY11 according to Research!America’€™s 2011 U.S. Investment in Health Research report. This represents the first drop in overall spending since Research!America began compiling the data in 2002. The decline follows an uptick in research funding attributed to the American Recovery and Reinvestment Act (ARRA), which allocated $10.4 billion to the National Institutes of Health (NIH) over two fiscal years (2009-2010). The overall...
Why do you think we should be investing in global health research and development? Research!America has just released ’€œTop 10 Reasons Why the U.S. Should Invest in Global Health R&D.’€ This evidence-based list provides compelling reasons why these investments are critical for the U.S., ranging from the humanitarian benefits to research as a powerful driver of U.S. economic activity. The list can be found on Research!America’€™s new Global Health R&D Advocacy website . The site introduces Research!America’€™s new initiative for neglected tropical diseases (NTDs), including a recently released fact sheet on NTDs in the U.S. Additional NTD resources include a global health budget...
Diane Rehm; John F. Crowley ; Dr. John Mendelsohn; Dr. Mark Rosenberg; and California Institute for Regenerative Medicine to Receive 2013 Research!America Advocacy Awards WASHINGTON-October 2, 2012 - Research!America’s 17 th annual Advocacy Awards will convene leaders from government, academia, industry and health advocacy organizations to honor leading medical and health research advocates of our time. The event will take place on the evening of Wednesday, March 13, 2013, at the Andrew W. Mellon Auditorium in Washington, DC. The 2013 Advocacy Award winners are Diane Rehm, author and host of WAMU 88.5 and NPR’s “The Diane Rehm Show;” John F. Crowley, patient advocate and inspirational...
On September 29 th , World Heart Day , the global health community will raise awareness about cardiovascular disease (CVD). Cardiovascular diseases range from heart failure, meaning the heart is not pumping enough blood, to a heart attack, which happens when blood vessels are damaged and blood flow to the heart is blocked. An estimated 17.3 million people died from CVD in 2008 and over 80% of all CVD deaths occur in low and middle income countries. This year, we are also raising awareness of one of CVD’€™s ’€œhidden causes’€ : neglected tropical diseases (NTDs), and of the research necessary to combat these killers. A group of parasitic and bacterial infections that disproportionately...
As reported in the Washington Post, the number of West Nile virus cases in the U.S. is on the rise. Traditionally a disease that affects people in Africa, the Middle East and Asia, 48 states in the U.S. have reported cases in 2012 alone. Nearly 2,000 cases and 87 deaths, including one Wednesday in DC, have been reported overall. The West Nile virus, a neglected tropical disease or NTD, can cause flu-like symptoms or, in severe cases, even brain damage. Peter Hotez, MD, PhD, director of the Texas-based product development partnership Sabin Vaccine Institute, recently wrote a New York Times op-ed addressing the increasing thread of West Nile right here in the U.S., ’€œTropical Disease: The...
Dear Research Advocate, As the political conventions get underway, we have further evidence that voters want candidates to make research for health a prominent issue, now and after the election. Our latest national public opinion poll, conducted a week ago, shows voters want to elect candidates who value and highly prioritize the importance of medical progress. Among the highlights: 90% say it’€™s important for candidates to address medical research; 59% say elected officials in Washington are not paying enough attention to combating deadly diseases, so much so that 63% say the next president should announce initiatives promoting medical progress in his ’€œfirst 100 days in office.’€ And...
Dear Research Advocate, With Rep. Paul Ryan joining the Romney ticket, health is back on the national agenda. Partisan politics aside, this conversation is overdue, since health is indeed an issue that will make or bankrupt us. Research has always figured prominently in the wellbeing of Americans and America ’€“ research brought an end to the polio epidemic, which could have bankrupted the nation in the 1950s, and research is the only answer to the scourge of Alzheimer’€™s that threatens health, quality of life and our national checkbook today. And that is just a starting point for the conversation I hope you are having with everyone who wants to talk about the election. Take the...
Dear Research Advocate, American achievement continues to astound. This week we watched NASA’€™s Jet Propulsion Laboratory send one of the most advanced space exploration vehicles ever constructed to a planet hundreds of millions of miles away from Earth and elegantly deliver it to the planet’€™s surface. Mars today, why not a cure for our nation’€™s deadliest diseases tomorrow? As advocates, we cannot take no for answer when it comes to assuring we have the resources, policies and determination we need to defeat disease and disability. Why should we be reluctant to demand that this be a national priority? As Margaret Mead once said, ’€œNever doubt that a small group of thoughtful,...
Dear Research Advocate, Just before leaving Washington for five weeks, Congressional leaders Harry Reid and John Boehner announced agreement on a continuing resolution (’€œC.R.’€) to fund the government until March 2013. In what has become routine, appropriations decisions will be deferred far beyond the October 1 beginning of the federal fiscal year. The leaders’€™ agreement, motivated by the need to avert a government shutdown, would leave NIH, FDA, AHRQ, CDC and the NSF with steady-state budgets, which is at least a better outcome than proposals for cuts pending before the House right now. But don’€™t take your eye off the ball! All kinds of mischief is possible between now and March,...

Pages

Sidebar Quote

Funding research gives all of us a better chance of living a healthier life.
Pam Hirata, heart disease survivor